Sarcopenia, a progressive disease characterized by a decline in muscle strength, quality,
and mass, affects aging population worldwide, leading to increased morbidity and mortality …

Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are a leading
cause of hospitalisation and death in COPD patients. In addition to the identification of better …

Background: Despite the known benefits of pulmonary rehabilitation (PR) for patients with
chronic respiratory disease, this treatment is underused. Evidence-based guidelines should …

This article details the GesEPOC 2021 recommendations on the diagnosis and treatment of
COPD exacerbation syndrome (CES). The guidelines propose a definition-based syndromic …

Health initiatives worldwide demand affordable point-of-care devices to aid in the reduction
of morbidity and mortality rates of high-incidence infectious and noncommunicable …

Background Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are
associated with changes in the sputum microbiome, including an increased prevalence of …

Pulmonary delivery is an alternative route of administration with numerous advantages over
conventional routes of administration. It provides low enzymatic exposure, fewer systemic …

The studies on the composition of the human microbiomes in healthy individuals, its
variability in the course of inflammation, infection, antibiotic therapy, diets and different …

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory airway disease
characterized by progressive airflow limitation. The complex biological processes of COPD …

Purpose NT-proBNP, a peptide biomarker synthesized and secreted by cardiomyocytes in
response to cardiac load, has gained attention in recent years for its potential role in …